Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.

He H, Sinha I, Fan R, Haldosen LA, Yan F, Zhao C, Dahlman-Wright K.

Oncogene. 2018 May;37(19):2586-2600. doi: 10.1038/s41388-018-0165-8. Epub 2018 Feb 22.

PMID:
29467493
2.

Adipocyte Expression of SLC19A1 Links DNA Hypermethylation to Adipose Tissue Inflammation and Insulin Resistance.

Petrus P, Bialesova L, Checa A, Kerr A, Naz S, Bäckdahl J, Gracia A, Toft S, Dahlman-Wright K, Hedén P, Dahlman I, Wheelock CE, Arner P, Mejhert N, Gao H, Rydén M.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):710-721. doi: 10.1210/jc.2017-01382.

PMID:
29121255
3.

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α.

Bialesova L, Xu L, Gustafsson JÅ, Haldosen LA, Zhao C, Dahlman-Wright K.

Oncotarget. 2017 Sep 4;8(44):76622-76633. doi: 10.18632/oncotarget.20635. eCollection 2017 Sep 29.

4.
5.

17β-Estradiol suppresses visceral adipogenesis and activates brown adipose tissue-specific gene expression.

Al-Qahtani SM, Bryzgalova G, Valladolid-Acebes I, Korach-André M, Dahlman-Wright K, Efendić S, Berggren PO, Portwood N.

Horm Mol Biol Clin Investig. 2017 Jan 1;29(1):13-26. doi: 10.1515/hmbci-2016-0031.

PMID:
27831918
6.

Estrogen Enhances the Expression of the Polyunsaturated Fatty Acid Elongase Elovl2 via ERα in Breast Cancer Cells.

González-Bengtsson A, Asadi A, Gao H, Dahlman-Wright K, Jacobsson A.

PLoS One. 2016 Oct 27;11(10):e0164241. doi: 10.1371/journal.pone.0164241. eCollection 2016.

7.

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.

Diao Y, Azatyan A, Rahman MF, Zhao C, Zhu J, Dahlman-Wright K, Zaphiropoulos PG.

Oncotarget. 2016 Nov 1;7(44):71580-71593. doi: 10.18632/oncotarget.12259.

8.

AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression.

Qiao Y, He H, Jonsson P, Sinha I, Zhao C, Dahlman-Wright K.

J Biol Chem. 2016 Aug 26;291(35):18309. doi: 10.1074/jbc.A115.702571. No abstract available.

9.

Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

Jia M, Andreassen T, Jensen L, Bathen TF, Sinha I, Gao H, Zhao C, Haldosen LA, Cao Y, Girnita L, Moestue SA, Dahlman-Wright K.

Cancer Res. 2016 Oct 1;76(19):5634-5646. Epub 2016 Jul 25.

10.

Expression of sex steroid hormone receptors in human skeletal muscle during the menstrual cycle.

Ekenros L, Papoutsi Z, Fridén C, Dahlman Wright K, Lindén Hirschberg A.

Acta Physiol (Oxf). 2017 Feb;219(2):486-493. doi: 10.1111/apha.12757. Epub 2016 Aug 9.

PMID:
27438889
11.

Peroxisome Proliferator-activated Receptor γ Coactivator-1 α Isoforms Selectively Regulate Multiple Splicing Events on Target Genes.

Martínez-Redondo V, Jannig PR, Correia JC, Ferreira DM, Cervenka I, Lindvall JM, Sinha I, Izadi M, Pettersson-Klein AT, Agudelo LZ, Gimenez-Cassina A, Brum PC, Dahlman-Wright K, Ruas JL.

J Biol Chem. 2016 Jul 15;291(29):15169-84. doi: 10.1074/jbc.M115.705822. Epub 2016 May 26.

12.

Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients.

Kirchner H, Sinha I, Gao H, Ruby MA, Schönke M, Lindvall JM, Barrès R, Krook A, Näslund E, Dahlman-Wright K, Zierath JR.

Mol Metab. 2016 Jan 2;5(3):171-183. doi: 10.1016/j.molmet.2015.12.004. eCollection 2016 Mar.

13.

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism.

Correia JC, Massart J, de Boer JF, Porsmyr-Palmertz M, Martínez-Redondo V, Agudelo LZ, Sinha I, Meierhofer D, Ribeiro V, Björnholm M, Sauer S, Dahlman-Wright K, Zierath JR, Groen AK, Ruas JL.

Mol Metab. 2015 Sep 26;4(12):891-902. doi: 10.1016/j.molmet.2015.09.005. eCollection 2015 Dec.

14.

The transcriptional coregulator MAML1 affects DNA methylation and gene expression patterns in human embryonic kidney cells.

Putnik M, Brodin D, Wojdacz TK, Fagerström-Billai F, Dahlman-Wright K, Wallberg AE.

Mol Biol Rep. 2016 Mar;43(3):141-50. doi: 10.1007/s11033-016-3946-6. Epub 2016 Feb 8.

PMID:
26857655
15.

AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.

Qiao Y, He H, Jonsson P, Sinha I, Zhao C, Dahlman-Wright K.

J Biol Chem. 2016 Mar 4;291(10):5068-79. doi: 10.1074/jbc.M115.702571. Epub 2016 Jan 20. Erratum in: J Biol Chem. 2016 Aug 26;291(35):18309.

16.

Differential methylation in inflammation and type 2 diabetes genes in siblings born before and after maternal bariatric surgery.

Berglind D, Müller P, Willmer M, Sinha I, Tynelius P, Näslund E, Dahlman-Wright K, Rasmussen F.

Obesity (Silver Spring). 2016 Jan;24(1):250-61. doi: 10.1002/oby.21340. Epub 2015 Dec 6.

17.

p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.

Zhuang T, Zhu J, Li Z, Lorent J, Zhao C, Dahlman-Wright K, Strömblad S.

Oncotarget. 2015 Dec 22;6(41):43853-68. doi: 10.18632/oncotarget.6081.

18.

Identification of proteins highly expressed in uterine fluid from mice with hydrometra.

Antonson P, Nalvarte I, Varshney M, Xu L, Windahl SH, Humire P, Ohlsson C, Gustafsson JÅ, Dahlman-Wright K.

Biochem Biophys Res Commun. 2015 Oct 30;466(4):650-5. doi: 10.1016/j.bbrc.2015.09.099. Epub 2015 Sep 21.

PMID:
26393907
19.

Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells.

Borbely G, Haldosen LA, Dahlman-Wright K, Zhao C.

Oncotarget. 2015 Oct 20;6(32):33623-35. doi: 10.18632/oncotarget.5601.

20.

The epigenetic signature of subcutaneous fat cells is linked to altered expression of genes implicated in lipid metabolism in obese women.

Arner P, Sinha I, Thorell A, Rydén M, Dahlman-Wright K, Dahlman I.

Clin Epigenetics. 2015 Sep 8;7:93. doi: 10.1186/s13148-015-0126-9. eCollection 2015.

21.

Estrogen receptor alpha and beta in health and disease.

Jia M, Dahlman-Wright K, Gustafsson JÅ.

Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):557-68. doi: 10.1016/j.beem.2015.04.008. Epub 2015 Apr 26. Review.

PMID:
26303083
22.

RING finger protein 31 promotes p53 degradation in breast cancer cells.

Zhu J, Zhao C, Zhuang T, Jonsson P, Sinha I, Williams C, Strömblad S, Dahlman-Wright K.

Oncogene. 2016 Apr 14;35(15):1955-64. doi: 10.1038/onc.2015.260. Epub 2015 Jul 6.

23.

The fat cell epigenetic signature in post-obese women is characterized by global hypomethylation and differential DNA methylation of adipogenesis genes.

Dahlman I, Sinha I, Gao H, Brodin D, Thorell A, Rydén M, Andersson DP, Henriksson J, Perfilyev A, Ling C, Dahlman-Wright K, Arner P.

Int J Obes (Lond). 2015 Jun;39(6):910-9. doi: 10.1038/ijo.2015.31. Epub 2015 Mar 18.

PMID:
25783037
24.

AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer.

Qiao Y, Shiue CN, Zhu J, Zhuang T, Jonsson P, Wright AP, Zhao C, Dahlman-Wright K.

Oncotarget. 2015 Apr 10;6(10):7804-14.

25.

Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue.

Gao H, Mejhert N, Fretz JA, Arner E, Lorente-Cebrián S, Ehrlund A, Dahlman-Wright K, Gong X, Strömblad S, Douagi I, Laurencikiene J, Dahlman I, Daub CO, Rydén M, Horowitz MC, Arner P.

Cell Metab. 2014 Jun 3;19(6):981-92. doi: 10.1016/j.cmet.2014.03.032. Epub 2014 May 22.

26.

Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.

Zhao C, Qiao Y, Jonsson P, Wang J, Xu L, Rouhi P, Sinha I, Cao Y, Williams C, Dahlman-Wright K.

Cancer Res. 2014 Jul 15;74(14):3983-94. doi: 10.1158/0008-5472.CAN-13-3396. Epub 2014 May 15.

27.

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.

Rizza P, Barone I, Zito D, Giordano F, Lanzino M, De Amicis F, Mauro L, Sisci D, Catalano S, Dahlman Wright K, Gustafsson JA, Andò S.

Breast Cancer Res. 2014 Feb 19;16(1):R21. doi: 10.1186/bcr3619.

28.

The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.

Zhu J, Zhao C, Kharman-Biz A, Zhuang T, Jonsson P, Liang N, Williams C, Lin CY, Qiao Y, Zendehdel K, Strömblad S, Treuter E, Dahlman-Wright K.

Oncogene. 2014 Aug 21;33(34):4340-51. doi: 10.1038/onc.2013.573. Epub 2014 Jan 20.

29.

aP2-Cre-mediated inactivation of estrogen receptor alpha causes hydrometra.

Antonson P, Matic M, Portwood N, Kuiper RV, Bryzgalova G, Gao H, Windahl SH, Humire P, Ohlsson C, Berggren PO, Gustafsson JÅ, Dahlman-Wright K.

PLoS One. 2014 Jan 8;9(1):e85581. doi: 10.1371/journal.pone.0085581. eCollection 2014.

30.

Expression of activator protein-1 (AP-1) family members in breast cancer.

Kharman-Biz A, Gao H, Ghiasvand R, Zhao C, Zendehdel K, Dahlman-Wright K.

BMC Cancer. 2013 Sep 28;13:441. doi: 10.1186/1471-2407-13-441.

31.

Implications of estrogen receptor alpha and estrogen receptor beta for adipose tissue functions and cardiometabolic complications.

Gao H, Dahlman-Wright K.

Horm Mol Biol Clin Investig. 2013 Sep;15(3):81-90. doi: 10.1515/hmbci-2013-0021. Review.

PMID:
25436735
32.

Estrogen receptor beta in breast cancer.

Haldosén LA, Zhao C, Dahlman-Wright K.

Mol Cell Endocrinol. 2014 Jan 25;382(1):665-672. doi: 10.1016/j.mce.2013.08.005. Epub 2013 Aug 15. Review.

33.

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.

Matic M, Bryzgalova G, Gao H, Antonson P, Humire P, Omoto Y, Portwood N, Pramfalk C, Efendic S, Berggren PO, Gustafsson JÅ, Dahlman-Wright K.

PLoS One. 2013;8(2):e57458. doi: 10.1371/journal.pone.0057458. Epub 2013 Feb 25.

34.

Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.

Windahl SH, Börjesson AE, Farman HH, Engdahl C, Movérare-Skrtic S, Sjögren K, Lagerquist MK, Kindblom JM, Koskela A, Tuukkanen J, Divieti Pajevic P, Feng JQ, Dahlman-Wright K, Antonson P, Gustafsson JÅ, Ohlsson C.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2294-9. doi: 10.1073/pnas.1220811110. Epub 2013 Jan 23.

35.

Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression.

Gustafsson Sheppard N, Heldring N, Dahlman-Wright K.

J Mol Endocrinol. 2012 Oct 30;49(3):277-87. doi: 10.1530/JME-12-0073. Print 2012 Dec.

PMID:
23042805
36.

Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.

Putnik M, Zhao C, Gustafsson JÅ, Dahlman-Wright K.

Biochem Biophys Res Commun. 2012 Sep 14;426(1):26-32. doi: 10.1016/j.bbrc.2012.08.007. Epub 2012 Aug 10.

PMID:
22902638
37.

Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.

Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JÅ, Williams C, Zhao C.

Carcinogenesis. 2012 Sep;33(9):1684-91. doi: 10.1093/carcin/bgs223. Epub 2012 Jul 12.

PMID:
22791811
38.

Adipose tissue microRNAs as regulators of CCL2 production in human obesity.

Arner E, Mejhert N, Kulyté A, Balwierz PJ, Pachkov M, Cormont M, Lorente-Cebrián S, Ehrlund A, Laurencikiene J, Hedén P, Dahlman-Wright K, Tanti JF, Hayashizaki Y, Rydén M, Dahlman I, van Nimwegen E, Daub CO, Arner P.

Diabetes. 2012 Aug;61(8):1986-93. doi: 10.2337/db11-1508. Epub 2012 Jun 11.

39.

The transcription factor encyclopedia.

Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW.

Genome Biol. 2012;13(3):R24. doi: 10.1186/gb-2012-13-3-r24.

40.

Gene expression of estrogen receptors in PBMC from patients with Puumala virus infection.

Brundin P, Zhao C, Dahlman-Wright K, Ahlm C, Evengård B.

Shock. 2012 Apr;37(4):355-9. doi: 10.1097/SHK.0b013e31824ae41e.

PMID:
22266976
41.

Metabolic diseases and cancer risk.

Faulds MH, Dahlman-Wright K.

Curr Opin Oncol. 2012 Jan;24(1):58-61. doi: 10.1097/CCO.0b013e32834e0582. Review.

PMID:
22123235
42.

Developmental toxicity of the environmental pollutant 4-nonylphenol in zebrafish.

Chandrasekar G, Arner A, Kitambi SS, Dahlman-Wright K, Lendahl MA.

Neurotoxicol Teratol. 2011 Nov-Dec;33(6):752-64. doi: 10.1016/j.ntt.2011.09.009. Epub 2011 Oct 5.

PMID:
22002180
43.

From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer.

Gao H, Dahlman-Wright K.

EMBO J. 2011 Jul 6;30(13):2516-7. doi: 10.1038/emboj.2011.205. No abstract available.

44.

Genome wide association study identifies KCNMA1 contributing to human obesity.

Jiao H, Arner P, Hoffstedt J, Brodin D, Dubern B, Czernichow S, van't Hooft F, Axelsson T, Pedersen O, Hansen T, Sørensen TI, Hebebrand J, Kere J, Dahlman-Wright K, Hamsten A, Clement K, Dahlman I.

BMC Med Genomics. 2011 Jun 28;4:51. doi: 10.1186/1755-8794-4-51.

45.

Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.

Goumidi L, Dahlman-Wright K, Tapia-Paez I, Matsson H, Pasquier F, Amouyel P, Kere J, Lambert JC, Meirhaeghe A.

J Alzheimers Dis. 2011;26(3):431-9. doi: 10.3233/JAD-2011-110362.

PMID:
21673408
46.

Early transcriptional regulation by C-peptide in freshly isolated rat proximal tubular cells.

Lindahl E, Nordquist L, Müller P, El Agha E, Friederich M, Dahlman-Wright K, Palm F, Jörnvall H.

Diabetes Metab Res Rev. 2011 Oct;27(7):697-704. doi: 10.1002/dmrr.1220.

PMID:
21618400
47.

The diversity of sex steroid action: regulation of metabolism by estrogen signaling.

Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JÅ.

J Endocrinol. 2012 Jan;212(1):3-12. doi: 10.1530/JOE-11-0044. Epub 2011 Apr 21. Review.

PMID:
21511884
48.

Genetic association and gene expression analysis identify FGFR1 as a new susceptibility gene for human obesity.

Jiao H, Arner P, Dickson SL, Vidal H, Mejhert N, Henegar C, Taube M, Hansson C, Hinney A, Galan P, Simon C, Silveira A, Benrick A, Jansson JO, Bouloumié A, Langin D, Laville M, Debard C, Axelsson T, Rydén M, Kere J, Dahlman-Wright K, Hamsten A, Clement K, Dahlman I.

J Clin Endocrinol Metab. 2011 Jun;96(6):E962-6. doi: 10.1210/jc.2010-2639. Epub 2011 Mar 23.

PMID:
21430024
49.

Fatty acids derived from royal jelly are modulators of estrogen receptor functions.

Moutsatsou P, Papoutsi Z, Kassi E, Heldring N, Zhao C, Tsiapara A, Melliou E, Chrousos GP, Chinou I, Karshikoff A, Nilsson L, Dahlman-Wright K.

PLoS One. 2010 Dec 22;5(12):e15594. doi: 10.1371/journal.pone.0015594.

50.

Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.

Wang X, Björklund S, Wasik AM, Grandien A, Andersson P, Kimby E, Dahlman-Wright K, Zhao C, Christensson B, Sander B.

PLoS One. 2010 Nov 22;5(11):e14085. doi: 10.1371/journal.pone.0014085.

Supplemental Content

Loading ...
Support Center